IMATINIB SAMITIB 400 MG TAB Exporter | India Supplier – City Drug Exporters IMATINIB SAMITIB 400 MG TAB.
City Drug Exporters supplies genuine pharma Products with bulk supply & global delivery
Key Pharmacological Aspects:
1. Mechanism of Action: Samitib inhibits the BCR-ABL tyrosine kinase, which is created by the Philadelphia chromosome abnormality in CML and Ph+ ALL. By inhibiting this enzyme and other receptor tyrosine kinases (PDGF and c-Kit), it disrupts signaling pathways, reducing abnormal cell proliferation.
2.Formulation: Each tablet contains 400 mg of Imatinib.
3.Dosage & Administration: Orally, once or twice daily with food to minimize gastric irritation.
Indications :
1.Chronic myeloid leukemia (CML)
2.Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL)
3.Gastrointestinal stromal tumors (GIST)
4.Other malignancies like myelodysplastic/myeloproliferative diseases and aggressive systemic mastocytosis
City Drug Exporters is a trusted Indian pharmaceutical exporter supplying IMATINIB SAMITIB 400 MG TAB in bulk quantities to international markets with strict quality control and regulatory compliance.
IMATINIB SAMITIB 400 MG TAB Supplier, Dealer, Exporter
We City drug house exporters Is The Leading Supplier, Dealer, Exporter For IMATINIB SAMITIB 400 MG TAB In washington, USA and Nagpur INDIA.
